Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Leaf extracts were evaluated for antihyperglycemic effects in healthy volunteers via oral glucose tolerance tests, as well as testing for alpha-glucosidase inhibition and insulin stimulation [PMID:25709220]
Ethanol extract significantly decreased total cholesterol, low density lipoprotein (LDL), triglyceride levels, and proinflammatory cytokines (IL-6) in a rat model [PMID:38948314]
Water extracts were investigated for the ability to reverse clusters of diseases in a fructose-induced rat model [PMID:31462242]
Crude alcoholic and base extracts obstructed amyloid-beta aggregation, with base extract inhibiting nucleation in SH-SY5Y cells [PMID:36235616]
Ethanolic extracts demonstrated antimicrobial potentials against Escherichia coli and Staphylococcus aureus [PMID:39141632]
Synthèse des preuves
Sources PubMed
- 1.PMID: 34673338 (2021) — Ultrasound-assisted encapsulation of Pandan (Pandanus amaryllifolius) extract. · Ultrasonics sonochemistry
- 2.PMID: 39053743 (2024) — Botany, phytochemistry, pharmacology, and applications of Pandanus amaryllifolius Roxb.: A review. · Fitoterapia
- 3.PMID: 25709220 (2015) — Antihyperglycemic effects of Pandanus amaryllifolius Roxb. leaf extract. · Pharmacognosy magazine
- 4.PMID: 30850030 (2019) — Recent Progress in the Chemistry of Pandanus Alkaloids. · The Alkaloids. Chemistry and biology
- 5.PMID: 36235616 (2022) — Pandanus amaryllifolius Exhibits In Vitro Anti-Amyloidogenic Activity and Promotes Neuroprotective Effects in Amyloid-β-Induced SH-SY5Y Cells.